Frontlight ResearchEarly access
Colorectal cancer trials in Spain
121 of 147 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 623 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 1/2Taking peopleA Phase 1/2 Study of IAM1363 in HER2 Cancers
- Where
- Barcelona, Madrid, Málaga, Seville, Valencia
- Age
- 18 years and over
- People
- 463 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 · EU 2024-519188-17-00 - Phase 2Taking peopleA Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Where
- Madrid
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07659795 · EU 2026-526473-42-00 - Phase 1/2Taking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Seville, Valencia
- Age
- 18 years and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - Phase 1/2Taking peopleA Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 47 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07213609 - Phase 2Not yet taking people in SpainA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- Where
- Barcelona, Madrid, Málaga, Santiago de Compostela, Valencia
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00 - Phase 3Taking peopleCAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected metastatic colorectal cancer patients
- Where
- Barcelona, Cartagena, Córdoba, Granada, Madrid, Málaga, Pamplona, Santander
- Age
- 18 years and over
- People
- 360 worldwide
- Run by
- Gruppo Oncologico Dell'Italia Meridionale
See details and how to join2024-519322-20-00 - Phase 3Not yet taking people in SpainStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
- Where
- Badalona, Barcelona, Elche, L'Hospitalet de Llobregat, Lleida, Madrid, Majadahonda, Málaga, Pamplona, Pozuelo de Alarcón, Torrejón de Ardoz, Valencia, Zaragoza
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Genmab A/S
See details and how to join2026-525883-17-00 - Phase 2Taking peopleA Study to Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic Colorectal Cancer Patients After Previous Therapy With BRAF Inhibitors-based Combinations
- Where
- Barcelona
- Age
- 18 years and over
- People
- 25
- Run by
- Vall d'Hebron Institute of Oncology
See details and how to joinNCT07178717 · EU 2023-509564-22-00 - Phase 1/2Not yet taking people in SpainA Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- Where
- Barcelona
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- SOTIO Biotech a.s.
See details and how to joinNCT07693751 · EU 2026-526235-19-00 - Phase 1Taking peopleA Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT06004245 · EU 2023-503170-20-01 - Phase 1Taking peopleA Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Logroño, Madrid
- Age
- 18 years and over
- People
- 124 worldwide
- Run by
- Pliant Therapeutics, Inc.
See details and how to joinNCT06270706 - Phase 3Taking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Badalona, Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Sevilla, Valencia
- Age
- 18 years and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - Phase 2Not yet taking people in SpainNeoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Solstice Oncology, Inc.
See details and how to joinNCT07808151 · EU 2026-527233-58-00 - Phase 3Taking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - Phase 1/2Taking peopleA Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Where
- Barcelona, Logroño, Madrid
- Age
- 18 years and over
- People
- 616 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07020221 - Phase 1Taking peopleA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Where
- Logrono, Madrid, Valencia
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07503808 · EU 2026-526299-21-00 - Phase 1Taking peopleA Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Where
- Barcelona, Donostia, Madrid, Majadahonda, Valencia, Zaragoza
- Age
- 18 years and over
- People
- 542 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT04929223 · EU 2023-505163-37-00 - Phase 3Taking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- A Coruña, Barcelona, Córdoba, Granada, Madrid, Málaga, Palma de Mallorca, Santander, Seville, Valencia
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - Phase 1Not yet taking people in SpainA Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid, Valencia
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- Pfizer
See details and how to joinNCT07318805 · EU 2025-524387-38-00 - Phase 3Taking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Barcelona, Córdoba, Madrid, Sevilla, Valencia
- Age
- 18 years and over
- People
- 1,020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Barcelona, Madrid, Valencia
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 2Taking peopleA Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Where
- Barcelona, Las Palmas, Madrid, Málaga, Pamplona, Valencia
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06695845 · EU 2024-516551-41-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 1Not yet taking people in SpainA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00